Clin Endosc.  2021 Jul;54(4):548-554. 10.5946/ce.2020.236.

Is Endoscopic Band Ligation a Superior Treatment Modality for Gastric Antral Vascular Ectasia Compared to Argon Plasma Coagulation?

Affiliations
  • 1Department of Gastroenterology, University Hospital Galway, Galway, Ireland

Abstract

Background/Aims
Gastric antral vascular ectasia (GAVE) is a rare acquired vascular lesion of the gastric antrum. The most frequent presentation of GAVE is iron deficiency anemia. Endoscopic therapy is the mainstay of treatment. However, there is no consensus regarding the optimal treatment modality.
Methods
A retrospective cohort study was performed on patients with GAVE, including patients receiving endoscopic therapy. Treatment was with either argon plasma coagulation (APC) or endoscopic band ligation (EBL). Basic demographic data, indication for index procedure, number of sessions, and pre- and post-hemoglobin levels were collected. The aim of the study was to compare outcomes across the two treatment modalities.
Results
One hundred and seventeen diagnoses of GAVE were made. Sixty-two patients (53%) required endoscopic treatment for symptomatic GAVE (female, n=38, 61%; mean age of 74.4 years). Two hundred and eighteen procedures were performed during the study period. APC was performed (n=161, 74%) more frequently than EBL (n=57, 26%). Patients treated with APC at index required a median 5 subsequent therapeutic interventions (APC or EBL), while those treated with EBL at index required a further 2.9 treatments (EBL only) (p<0.05).
Conclusions
APC was the most common treatment modality employed. We demonstrate an increasing incidence of EBL. Patients treated with EBL at index treatment required fewer subsequent treatment sessions and had a greater mean rise in hemoglobin. This suggests a more effective endoscopic response with EBL.

Keyword

Anemia, iron-deficiency; Argon plasma coagulation; Endoscopic band ligation; Gastric antral vascular ectasia; Retrospective study

Figure

  • Fig. 1. Endoscopic appearance of gastric antral vascular ectasia; diffuse disorganised and nodular pattern located in the antrum (A), or in prominent organised streaks and stripes emanating from the pylorus resembling the stripes of a watermelon (B).

  • Fig. 2. (A, B) Treatment of gastric antral vascular ectasia with argon plasma coagulation.

  • Fig. 3. (A, B) Treatment of gastric antral vascular ectasia with endoscopic band ligation.

  • Fig. 4. Flowchart of included/excluded patients and index treatment modality. APC, argon plasma coagulation; EBL, endoscopic band ligation; GAVE, gastric antral vascular ectasia.

  • Fig. 5. Indication for upper gastrointestinal endoscopy in patients treated for moderate to severe gastric antral vascular ectasia.

  • Fig. 6. Treatment sessions following index treatment (n=63). APC, argon plasma coagulation; EBL, endoscopic band ligation.

  • Fig. 7. Blood transfusion requirements (units) per group pre and post intervention. APC, argon plasma coagulation; EBL, endoscopic band ligation.


Reference

1. Suit PF, Petras RE, Bauer TW, Petrini JL Jr. Gastric antral vascular ectasia. A histologic and morphometric study of “the watermelon stomach”. Am J Surg Pathol. 1987; 11:750–757.
2. Gilliam JH 3rd, Geisinger KR, Wu WC, Weidner N, Richter JE. Endoscopic biopsy is diagnostic in gastric antral vascular ectasia. The “watermelon stomach”. Dig Dis Sci. 1989; 34:885–888.
3. Lewis TD, Laufer I, Goodacre RL. Arteriovenous malformation of the stomach. Radiologic and endoscopic features. Am J Dig Dis. 1978; 23:467–471.
4. Jabbari M, Cherry R, Lough JO, Daly DS, Kinnear DG, Goresky CA. Gastric antral vascular ectasia: the watermelon stomach. Gastroenterology. 1984; 87:1165–1170.
Article
5. Petrini JL Jr, Johnston JH. Heat probe treatment for antral vascular ectasia. Gastrointest Endosc. 1989; 35:324–328.
Article
6. Binmoeller KF, Katon RM. Bipolar electrocoagulation for watermelon stomach. Gastrointest Endosc. 1990; 36:399–402.
Article
7. Rose JD. Endoscopic injection of alcohol for bleeding from gastroduodenal vascular anomalies. Br Med J (Clin Res Ed). 1987; 295:93–94.
Article
8. Sargeant IR, Loizou LA, Rampton D, Tulloch M, Bown SG. Laser ablation of upper gastrointestinal vascular ectasias: long term results. Gut. 1993; 34:470–475.
Article
9. Wahab PJ, Mulder CJ, den Hartog G, Thies JE. Argon plasma coagulation in flexible gastrointestinal endoscopy: pilot experiences. Endoscopy. 1997; 29:176–181.
Article
10. Herrera S, Bordas JM, Llach J, et al. The beneficial effects of argon plasma coagulation in the management of different types of gastric vascular ectasia lesions in patients admitted for GI hemorrhage. Gastrointest Endosc. 2008; 68:440–446.
Article
11. Kwan V, Bourke MJ, Williams SJ, et al. Argon plasma coagulation in the management of symptomatic gastrointestinal vascular lesions: experience in 100 consecutive patients with long-term follow-up. Am J Gastroenterol. 2006; 101:58–63.
Article
12. Chaves DM, Sakai P, Oliveira CV, Cheng S, Ishioka S. Watermelon stomach: clinical aspects and treatment with argon plasma coagulation. Arq Gastroenterol. 2006; 43:191–195.
Article
13. Yusoff I, Brennan F, Ormonde D, Laurence B. Argon plasma coagulation for treatment of watermelon stomach. Endoscopy. 2002; 34:407–410.
Article
14. Boltin D, Gingold-Belfer R, Lichtenstein L, Levi Z, Niv Y. Long-term treatment outcome of patients with gastric vascular ectasia treated with argon plasma coagulation. Eur J Gastroenterol Hepatol. 2014; 26:588–593.
Article
15. Nakamura S, Mitsunaga A, Konishi H, Oi I, Shiratori K, Suzuki S. Long-term follow up of gastric antral vascular ectasia treated by argon plasma coagulation. Dig Endosc. 2006; 18:128–133.
Article
16. Garg S, Aslam B, Nickl N. Endoscopic resolution and recurrence of gastric antral vascular ectasia after serial treatment with argon plasma coagulation. World J Gastrointest Endosc. 2017; 9:263–266.
Article
17. Jana T, Thosani N, Fallon MB, Dupont AW, Ertan A. Radiofrequency ablation for treatment of refractory gastric antral vascular ectasia (with video). Endosc Int Open. 2015; 3:E125–E127.
Article
18. Magee C, Lipman G, Alzoubaidi D, et al. Radiofrequency ablation for patients with refractory symptomatic anaemia secondary to gastric antral vascular ectasia. United European Gastroenterol J. 2019; 7:217–224.
Article
19. Wells CD, Harrison ME, Gurudu SR, et al. Treatment of gastric antral vascular ectasia (watermelon stomach) with endoscopic band ligation. Gastrointest Endosc. 2008; 68:231–236.
Article
20. Keohane J, Berro W, Harewood GC, Murray FE, Patchett SE. Band ligation of gastric antral vascular ectasia is a safe and effective endoscopic treatment. Dig Endosc. 2013; 25:392–396.
Article
21. Zepeda-Gómez S, Sultanian R, Teshima C, Sandha G, Van Zanten S, Montano-Loza AJ. Gastric antral vascular ectasia: a prospective study of treatment with endoscopic band ligation. Endoscopy. 2015; 47:538–540.
Article
22. Sato T, Yamazaki K, Akaike J. Endoscopic band ligation versus argon plasma coagulation for gastric antral vascular ectasia associated with liver diseases. Dig Endosc. 2012; 24:237–242.
Article
23. Eccles J, Falk V, Montano-Loza AJ, Zepeda-Gómez S. Long-term follow-up in patients with gastric antral vascular ectasia (GAVE) after treatment with endoscopic band ligation (EBL). Endosc Int Open. 2019; 7:E1624–E1629.
Article
24. Polski JM, Brunt EM, Saeed ZA. Chronology of histological changes after band ligation of esophageal varices in humans. Endoscopy. 2001; 33:443–447.
Article
Full Text Links
  • CE
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr